These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1678908)

  • 1. The unique effect of remoxipride on dopamine utilization in the basal ganglia.
    Fuxe K; Ogren SO
    Acta Physiol Scand; 1991 Apr; 141(4):577-8. PubMed ID: 1678908
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
    Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat.
    Ståhle L; Ljungberg T; Rodebjer A; Ogren SO; Ungerstedt U
    Pharmacol Toxicol; 1987 Mar; 60(3):227-32. PubMed ID: 2884654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses.
    Altar CA; Wasley AM; Liebman J; Gerhardt S; Kim H; Welch JJ; Wood PL
    Life Sci; 1986 Aug; 39(8):699-705. PubMed ID: 2874470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice.
    Zhang Y; Schlussman SD; Ho A; Kreek MJ
    Synapse; 2003 Dec; 50(3):191-9. PubMed ID: 14515336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diazepam and baclofen upon alpha-MSH-induced behavior related with cyclic AMP levels in accumbens and caudate putamen.
    De Barioglio SR; Cremer C; Celis ME
    Ann N Y Acad Sci; 1993 May; 680():591-3. PubMed ID: 8390198
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugs.
    Levant B; Bissette G; Widerlöv E; Nemeroff CB
    Regul Pept; 1991 Feb; 32(2):193-201. PubMed ID: 1674615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-cerebral cysteamine infusions attenuate the motor response to dopaminergic agonists.
    Lee N; Radke JM; Vincent SR
    Behav Brain Res; 1988 Jul; 29(1-2):179-83. PubMed ID: 2900014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenothiazine biphasic effect on dopamine concentrations in the basal ganglia of subhuman primates.
    Bird ED; Anton AH
    Psychiatry Res; 1982 Feb; 6(1):1-6. PubMed ID: 6949164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: further evidence for depolarization block.
    Chen JP; Paredes W; Gardner EL
    Neurosci Lett; 1991 Jan; 122(1):127-31. PubMed ID: 2057129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of local injections of dopamine and analogs into the neostriatum and nucleus accumbens.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():385-9. PubMed ID: 196491
    [No Abstract]   [Full Text] [Related]  

  • 12. Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat.
    Duty S; Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1998 Apr; 150(2):223-34. PubMed ID: 9527891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats.
    See RE; Chapman MA; Klitenick MA
    Brain Res; 1992 Aug; 588(1):177-80. PubMed ID: 1356587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
    Costall B; Naylor RJ; Cannon JG; Lee T
    J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.
    Di Chiara G; Vargiu L; Porceddu ML; Longoni R; Mulas A; Gessa GL
    Adv Biochem Psychopharmacol; 1977; 16():571-5. PubMed ID: 18901
    [No Abstract]   [Full Text] [Related]  

  • 17. 3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801.
    Dragunow M; Logan B; Laverty R
    Eur J Pharmacol; 1991 Mar; 206(3):255-8. PubMed ID: 1677338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration.
    Kurachi M; Shibata R; Murata M; Tanii Y
    Biol Psychiatry; 1995 Apr; 37(7):487-90. PubMed ID: 7786966
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of the tuberculum olfactorium in streotyped behaviour induced by apomorphine in the rat.
    McKenzie GM
    Psychopharmacologia; 1972; 23(3):212-9. PubMed ID: 5026945
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic prenatal haloperidol exposure: lack of effect on presynaptic dopamine autoreceptors.
    Scalzo FM; Newport GD; Gough BJ; Ali SF; Holson RR
    Neurotoxicology; 1989; 10(3):485-90. PubMed ID: 2516618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.